1. Yanagita M (2023) Clinical questions and good practice statements in clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 (manuscript in submission)
2. (2021) Nippon Kayaku Co., Ltd. Full prescribing information for Randa® (in Japanese). https://mink.nipponkayaku.co.jp/product/di/te_file/sedi_rani_te.pdf
3. (2015) The Japan Lung Cancer Society, and Japanese Society of Medical Oncology, guideline for short hydration method in cisplatin administration, Aug 2015, [Japanese], https://www.haigan.gr.jp/uploads/files/photos/1022.pdf
4. Sasaki Y, Tamura T, Eguchi K et al (1989) Pharmacokinetics of (glycolate-0,0’)-diammine platinum(II), a new platinum derivative, in comparison with cisplatin and carboplatin. Cancer Chemother Pharmacol 23:243–246
5. Filipski KK, Mathijssen RH, Mikkelsen TS et al (2009) Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. Clin Pharmacol Ther 86:396–402